Novo Nordisk (NYSE:NVO) Q1 2026 Earnings call May 06, 2026 07:00 AM ET Company ParticipantsEmil Kongshøj Larsen - EVP of International OperationsJamey Millar - EVP of US OperationsKarsten Munk Knudsen - CFOMartin Holst Lange - EVP of Research and Development and Chief Scientific OfficerMichael Novod - Head of Investor RelationsMike Doustdar - CEOConference Call ParticipantsCarsten Lønborg Madsen - AnalystEvan Seigerman - AnalystFlorent Cespedes - AnalystGraham Parry - AnalystJames Gordon - AnalystJames Quig ...

Novo Nordisk (NYSE:NVO) Q1 2026 Earnings call May 06, 2026 07:00 AM ET Company ParticipantsEmil Kongshøj Larsen - EVP of International OperationsJamey Millar - EVP of US OperationsKarsten Munk Knudsen - CFOMartin Holst Lange - EVP of Research and Development and Chief Scientific OfficerMichael Novod - Head of Investor RelationsMike Doustdar - CEOConference Call ParticipantsCarsten Lønborg Madsen - AnalystEvan Seigerman - AnalystFlorent Cespedes - AnalystGraham Parry - AnalystJames Gordon - AnalystJames Quig ...

RAFAEL VALVERDE Rafael lives with obesity Mexico Novo Nordisk – a focused healthcare company Investor presentation First three months of 2026 2 Novo Nordisk® Investor presentation First three months of 2026 Agenda Progress in 2026 Research & development Financials Commercial execution Agenda 3 Novo Nordisk® Investor presentation First three months of 2026 Forward-looking statements Novo Nordisk's statutory Annual Report 2025, Form 20-F, any quarterly financial reports, and written information released, show ...